Opioid

(Image: Getty/Kevron2001)

FDA aims to speed naloxone generics to market

By Ben Hargreaves

US FDA follows up the first generic approval of naloxone nasal spray by encouraging companies to apply with generic applications amid the North American opioid crisis.

GettyImages/juststock

Titan tests implant tech to curb opioid overdose

By Flora Southey

Titan has teamed with Opiant to investigate skin implant technology in the administration of opioid antagonists over extended periods, to combat opioid relapse and overdose in outpatients.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All